A human tumour model
- PMID: 2876282
- DOI: 10.1016/s0140-6736(86)92872-2
A human tumour model
Abstract
An approach to the management of patients with large (greater than 4 cm) operable breast cancers is described. The conventional sequence of mastectomy followed by systemic therapy is reversed, allowing accurate measurements of response to individual forms of endocrine therapy or chemotherapy. Such a method not only permits individual selection of appropriate systemic therapy, but also allows clinical response to be related to histological and biochemical tumour parameters. A response was observed in eleven of twenty-three patients to endocrine treatment and in twelve of thirteen to combination chemotherapy. In five of the latter the response was histologically complete.
Similar articles
-
Current strategies in operable breast cancer.Hosp Pract (Off Ed). 1987 Jan 30;22(1A):41-9, 53-4, 59-68. Hosp Pract (Off Ed). 1987. PMID: 3100553 Review. No abstract available.
-
Optimal management of ductal carcinoma in situ of the breast.Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8. Surg Oncol. 2003. PMID: 14998563 Review.
-
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.Clin Cancer Res. 1997 Sep;3(9):1565-9. Clin Cancer Res. 1997. PMID: 9815844
-
Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.Eur J Surg Oncol. 2016 Aug;42(8):1146-52. doi: 10.1016/j.ejso.2016.05.039. Epub 2016 Jun 23. Eur J Surg Oncol. 2016. PMID: 27365197
-
Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.Rev Esp Med Nucl Imagen Mol. 2012 May-Jun;31(3):117-23. doi: 10.1016/j.remn.2011.04.007. Epub 2011 Jun 14. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 21676504 Clinical Trial. English, Spanish.
Cited by
-
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.J Clin Med. 2019 May 6;8(5):612. doi: 10.3390/jcm8050612. J Clin Med. 2019. PMID: 31064127 Free PMC article.
-
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.Br J Cancer. 1988 Jul;58(1):77-80. doi: 10.1038/bjc.1988.166. Br J Cancer. 1988. PMID: 3166894 Free PMC article.
-
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).Br J Cancer. 1991 Feb;63(2):279-82. doi: 10.1038/bjc.1991.65. Br J Cancer. 1991. PMID: 1825469 Free PMC article. Clinical Trial.
-
Studies of apoptosis in breast cancer.BMJ. 2001 Jun 23;322(7301):1528-32. doi: 10.1136/bmj.322.7301.1528. BMJ. 2001. PMID: 11420276 Free PMC article. Review. No abstract available.
-
Primary systemic therapy for operable breast cancer.Br J Cancer. 1991 Apr;63(4):561-6. doi: 10.1038/bjc.1991.131. Br J Cancer. 1991. PMID: 1827031 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical